ARCHIVES

Obey Strikes Again, Earmarks NCI Positions

This article is from The Cancer Letter archive.

Vol. 02 No. 27 | July 2, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Payline For Fiscal 1986 To Be 160 or 165

October 11, 1985

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

Bunn Says ASCO Is “Strong, Diverse, Respected, Growing”

June 6, 2003

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999